Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (26)

2022

  1. Effect of lipoprotein (a) on the analytical determination of low-density lipoprotein cholesterol (LDLc) and its influence on pharmacological treatment with atorvastatin

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 82, Núm. 7-8, pp. 513-517

2021

  1. Immunotherapy-induced isolated ACTH deficiency in cancer therapy

    Endocrine-related cancer, Vol. 28, Núm. 12, pp. 783-792

2020

  1. GLP1 Receptor Agonist and SGLT2 Inhibitor Combination: An Effective Approach in Real-world Clinical Practice

    Clinical Therapeutics, Vol. 42, Núm. 2, pp. e1-e12

  2. Lat-1 and glut-1 carrier expression and its prognostic value in gastroenteropancreatic neuroendocrine tumors

    Cancers, Vol. 12, Núm. 10, pp. 1-18

2018

  1. Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age

    Oncology Letters, Vol. 13, Núm. 5, pp. 3501-3507

  2. Tendencias de la mortalidad por diabetes en España: por el buen camino

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 421-422

2015

  1. Thyroid pathology findings in Cowden syndrome: A clue for the diagnosis of the PTEN hamartoma tumor syndrome

    American Journal of Clinical Pathology, Vol. 144, Núm. 2, pp. 322-328

2013

  1. Pegvisomant and cabergoline combination therapy in acromegaly

    Pituitary, Vol. 16, Núm. 1, pp. 101-108

2012

  1. Axonal neuropathy, long limbs and bumpy tongue: Think of MEN2B

    Muscle and Nerve, Vol. 46, Núm. 6, pp. 961-964

  2. Bulky mass: Metastasis of poorly differentiated follicular thyroid carcinoma: A case report

    Clinical Nuclear Medicine, Vol. 37, Núm. 11, pp. 1131-1132

2011

  1. Betahidroxibutirato capilar en la monitorización de la cetoacidosis diabética

    Endocrinologia y Nutricion, Vol. 58, Núm. 7, pp. 347-352

  2. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis

    Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188

  3. Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)

    Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271

  4. Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus

    Diabetes Research and Clinical Practice, Vol. 91, Núm. 3

  5. Tratamiento de la hiperglucemia en la diabetes mellitus tipo 2: Hacia un tratamiento individualizado

    Medicine, Vol. 10, Núm. 92, pp. 6230-6239

  6. Utilidad del PET-FDG18 en la búsqueda del síndrome de Cushing ectópico por carcinoide bronquial oculto

    Endocrinologia y Nutricion

2010

  1. Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy

    Diabetic Medicine, Vol. 27, Núm. 10, pp. 1178-1187

2009

  1. Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus

    Chronobiology International, Vol. 26, Núm. 5, pp. 942-957

2008

  1. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain

    European Journal of Endocrinology, Vol. 159, Núm. 5, pp. 623-631